1. Home
  2. AIMD vs SPHL Comparison

AIMD vs SPHL Comparison

Compare AIMD & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • SPHL
  • Stock Information
  • Founded
  • AIMD 1984
  • SPHL 2002
  • Country
  • AIMD United States
  • SPHL Singapore
  • Employees
  • AIMD N/A
  • SPHL N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • SPHL Homebuilding
  • Sector
  • AIMD Health Care
  • SPHL Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • SPHL Nasdaq
  • Market Cap
  • AIMD 7.5M
  • SPHL 7.3M
  • IPO Year
  • AIMD N/A
  • SPHL 2024
  • Fundamental
  • Price
  • AIMD $0.54
  • SPHL $0.42
  • Analyst Decision
  • AIMD
  • SPHL
  • Analyst Count
  • AIMD 0
  • SPHL 0
  • Target Price
  • AIMD N/A
  • SPHL N/A
  • AVG Volume (30 Days)
  • AIMD 154.6K
  • SPHL 1.3M
  • Earning Date
  • AIMD 03-07-2025
  • SPHL 02-21-2025
  • Dividend Yield
  • AIMD N/A
  • SPHL N/A
  • EPS Growth
  • AIMD N/A
  • SPHL 413.11
  • EPS
  • AIMD N/A
  • SPHL 0.09
  • Revenue
  • AIMD $20,729.00
  • SPHL $11,020,429.00
  • Revenue This Year
  • AIMD N/A
  • SPHL N/A
  • Revenue Next Year
  • AIMD N/A
  • SPHL N/A
  • P/E Ratio
  • AIMD N/A
  • SPHL $5.06
  • Revenue Growth
  • AIMD N/A
  • SPHL 112.84
  • 52 Week Low
  • AIMD $0.40
  • SPHL $0.40
  • 52 Week High
  • AIMD $1.46
  • SPHL $7.80
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 51.16
  • SPHL N/A
  • Support Level
  • AIMD $0.46
  • SPHL N/A
  • Resistance Level
  • AIMD $0.57
  • SPHL N/A
  • Average True Range (ATR)
  • AIMD 0.05
  • SPHL 0.00
  • MACD
  • AIMD 0.00
  • SPHL 0.00
  • Stochastic Oscillator
  • AIMD 69.03
  • SPHL 0.00

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.

Share on Social Networks: